Table 1

Her-2 status and estrogen and progesterone receptor expression in female breast carcinoma patients in Jordan

Her-2 weak positive
 Her-2 strong positive
 Her-2 negative
 ER positive
 ER negative
 PR positive
 PR negative
Mean age (years)a
 43.7
 42.3
 53.2
 52.40
 43.68
 50.74
 45.71
No. of patients below 50 years of age
 15
 17
 18
 21
 29
 24
 26
No. of patients 50 years of age or older
 5
 5
 28
 26
 12
 22
 16
Mean size (cm)b
 4.9
 4.72
 4.02
 3.57
 5.3
 4.06
 4.79
No. of T1(up to 2 cm) tumors
 4
 4
 7
 9
 6
 8
 7
No. of T2 (more than 2 and up to 5 cm) tumors
 11
 11
 29
 29
 22
 29
 22
No. of T3 (more than 5 cm) tumors
 6
 7
 7
 6
 14
 7
 13
No lymph node metastasesc
 1
 3
 3
 2
 5
 3
 4
1–3 lymph node metastases
 3
 5
 8
 7
 9
 10
 6
More than 3 lymph node metastases
 9
 10
 8
 13
 14
 13
 14

aAge was unknown for three cases; bsize was unknown for five cases;

cdetermination of axillary lymph node status was limited to 50 patients who underwent lymph node dissection.

Almasri and Hamad Breast Cancer Research 2005 7:R598   doi:10.1186/bcr1200